STUDY QUESTION: What are the mechanisms by which corticotrophin-releasing hormone (CRH) and corticosterone impair the development of preimplantation embryos in the oviduct.
Introduction
It is known that stress can affect female reproduction in both human and animals. However, the mechanisms by which stress impairs embryo development are largely unknown. It has been reported that the vulnerability to stress changes during pregnancy and the early stages are more vulnerable than the later stages (Glynn et al., 2001; Hobel and Culhane, 2003) . The preimplantation/peri-implantation period is thus considered one of the most sensitive phases (Wilcox et al., 1999; Humblot, 2001) . However, studies on the effect of maternal preimplantation stress on embryo development are very limited. Although the limited studies have observed that preimplantation restraint stress significantly influenced the pre-and postimplantation development of mouse embryos (Burkuš et al., 2013 (Burkuš et al., , 2015 , the mechanisms by which stress is transmitted to the oviductal embryo are not clear.
Studies have shown that stress enhances the activity of the hypothalamus-pituitary-adrenal (HPA) axis and facilitates secretion of corticotrophin-releasing hormone (CRH) by the hypothalamus, adrenocorticotropic hormone by the pituitary, and glucocorticoids by the adrenal cortex. For example, restraint stress of mice elevated the level of CRH in both serum and ovarian homogenates (Liang et al., 2013) . Transport stress produces an immediate constant increase in arginine vasopressin and CRH secretion in ewes (Dobson and Smith, 2000) . Mice exposed to stress showed significant elevation of serum corticosterone and cortisol (Zhang et al., 2011; Gong et al., 2015) . Furthermore, exposure of sows to stress significantly elevated concentrations of cortisol and progesterone (Einarsson et al., 2008) . However, the mechanisms by which the HPA products affect embryos are largely unknown. So far, our knowledge on how HPA products affect embryos is mostly from in vivo studies, which do not allow an accurate specification of the roles of different hormones and cells within the complicated living organism. Furthermore, although our recent in vivo study observed that preimplantation maternal stress impaired mouse embryo development with elevated levels of CRH and glucocorticoids, increased oviductal apoptosis and activation of the Fas system (Zheng et al., 2016) , the results and conclusions of that study need further verification by direct in vitro evidences. For example, whether CRH or glucocorticoids would damage embryos directly or indirectly by way of oviductal cells remains to be clarified.
The aim of the present study was to explore whether CRH and corticosterone affect the preimplantation embryos directly or indirectly by inducing apoptosis of oviductal epithelial cells (OECs). The results showed that CRH and corticosterone impaired the development of mouse preimplantation embryos indirectly by inducing oviductal apoptosis via activating the Fas system. Mouse preimplantation embryos were insensitive to CRH due to a lack of CRH receptor (CRHR1) and they were tolerant to corticosterone because they express 11β-hydroxysteroid dehydrogenase (HSD)2 but not HSD1, leading to inactivation of corticosterone.
Materials and Methods
Unless otherwise specified, all chemicals and reagents used in this study were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Animals
Mice of Kunming strain, which were used for most of the experiments in this study, were originally derived from ICR (CD-1) mice. While the Kunming mice were bred in our laboratory, the generalized lymphoproliferative disorder (gld) mice with a germline mutation F273L in FasL in a C57BL/6J genomic background and the wild-type C57BL/6J mice were obtained from the Key Laboratory of Stem Cell Biology, Shanghai Institute for Biological Sciences, China. The mice were kept in a room under a 14L:10D photoperiod, with lights-off at 20:00.
Ethical approval
The experimental procedures used for animal care and handling were approved by the Animal Care and Use Committee of the Shandong Agricultural University, PR China (Permit number: SDAUA-2014-011). The methods were carried out in accordance with the approved guidelines.
Preparation of oviduct epithelium cells and conditioned medium
Female mice (8-10 weeks old) were killed 48 h after being injected with 10 IU equine chorionic gonadotrophin (eCG). Oviducts were removed immediately after death. Each oviduct was cut open and diced. Tissue blocks were digested with 0.25% trypsin at 37.5°C for 30 min and washed twice by centrifugation (200g, 5 min) . Pellets were resuspended in Dulbecco's Modified Eagles Medium/Ham's F12 (DMEM/F12, Gibco, Beijing, China) supplemented with 10% (v/v) fetal calf serum (Gibco) and 0.5% (v/v) penicillin-streptomycin solution (Gibco). The final suspension (1-2 × 10 5 cells/ml) was added to wells (200 μl per well) of a 96-well culture plate and cultured at 37.5°C in a humidified atmosphere of 5% CO 2 in air. At 24 h after seeding, medium was renewed first when most of the epithelial cells had attached, and medium was replaced every 48 h when culture was continued.
To prepare conditioned medium (CM), upon 90-100% confluence of the cultured OECs, the spent medium (DMEM/F12) was replaced with glucosefree or -containing Chatot-Ziomek-Bavister (CZB) medium with or without CRH or corticosterone and the growing OECs were cultured further for 48 h (Fig. 1) . Then, the spent medium was replaced with fresh CZB without hormones and incubated for 24 h. At the end of the culture, supernatants were collected and centrifuged at 1000g for 10 min to recover CM. The CM recovered was frozen and stored in aliquots at −20°C until use.
Collection of zygotes
Female mice, 8-10 weeks after birth, were induced to superovulate by using 10 IU eCG (i.p.) followed 48 h later by 10 IU hCG (i.p.). Females receiving hCG were placed with males (10-12 weeks old) overnight and examined for the presence of vaginal plugs 15 h later. Females with vaginal plugs were killed 23 h post hCG injection, and the oviductal ampullae were ruptured to release zygotes. Recovered zygotes were denuded of cumulus cells by pipetting in 0.1% hyaluronidase in M2 medium and washed in M2 medium before culture.
Embryo culture
Embryo culture was conducted at 37.5°C in a humidified atmosphere of 5% CO 2 in air using culture plates with each well containing 200 μl medium and 20-30 embryos.
Culture in CZB medium: Pronuclear embryos were first cultured for 48 h in glucose-free CZB with or without CRH or corticosterone, and then cultured for 48 h in CZB containing 5.6 mM glucose with or without CRH or corticosterone (Fig. 1) .
Co-culture with OECs: DMEM/F12 in wells with 90-100% confluent OECs was replaced with an equal amount of glucose-free CZB with or without CRH or corticosterone and cultured for 24 h (Fig. 1) . At the end of the culture, pronuclear embryos were introduced and first cultured for 48 h in glucose-free CZB without or with CRH or corticosterone, and then cultured for 48 h in glucose-containing CZB without or with CRH or corticosterone.
Culture in CM: Pronuclear embryos were first cultured for 48 h in glucosefree CM, and then cultured for 48 h in glucose-containing CM (Fig. 1) .
At the end of culture, embryo development was examined and some of the blastocysts were stained with Hoechst 33342 (10 μg/ml) for cell number counting under a fluorescence microscope. 
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Glucose-containing CZB without hormones Glucose-containing CZB with hormones Figure 1 A diagram showing the procedures for embryo culture in Chatot-Ziomek-Bavister (CZB) medium and co-culture with oviductal epithelial cells (OECs) and for preparation of conditioned medium (CM). For CZB culture, pronuclear embryos were first cultured for 48 h in glucose-free CZB without (Ctrl) or with corticotrophin-releasing hormone (CRH) or corticosterone (Treat), and then cultured for 48 h in glucose-containing CZB without or with CRH or corticosterone. For coculture, 90-100% confluent OECs were first cultured for 24 h in glucose-free CZB without or with CRH or corticosterone; pronuclear embryos were then introduced and cultured for 48 h in glucose-free CZB without or with CRH or corticosterone; and finally, embryos were cultured for 48 h in glucose-containing CZB without or with CRH or corticosterone. To prepare CM without (CM-G) or with glucose (CM+G), attached OECs were first cultured for 48 h in glucose-free or -containing CZB without (Ctrl-CM) or with CRH or corticosterone (Treat-CM), and then cultured for 24 h in glucose-free or -containing CZB without hormone before CM recovery. While dotted arrows indicate culture in glucose-free CZB, solid arrows represent culture in glucose-containing CZB. While gray arrows represent culture with CRH or corticosterone, blank arrows indicate culture without hormones.
Preparation of hormones and antagonists
CRH and corticosterone and their antagonists were added to CZB medium to observe their effects on embryos and OECs. For preparation, CRH (10 mM) was dissolved in water, corticosterone (10 mM) and RU486 (10 mM) in ethanol, and antalarmin (10 mM) in dimethylsulfoxide (DMSO). The stock solutions were stored at −20°C until use.
Immunofluorescence
Localization and/or quantification of CRHR1, glucocorticoid receptor (GR), activated capase-3 and Fas in embryos were performed by immunofluorescence microscopy. Briefly, embryos were (i) fixed for 30 min with 4% paraformaldehyde in PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA and 4 mM MgSO 4 , pH 7); (ii) permeabilized using 0.5% TritonX-100 to reveal activated capase-3 and GR (but the permeabilization procedure was omitted in the detection of Fas and CRHR1); (iii) blocked for 1 h in PHEM containing 3% bovine serum albumin (BSA); (iv) incubated with primary antibodies in M2 with 3% BSA at 4°C overnight; (v) incubated with secondary antibodies in M2 with 3% BSA for 1 h; (vi) incubated for 10 min in M2 containing 10 μg/ml of Hoechst 33342; and (vii) observed with a Leica laser-scanning confocal microscope (TCS, SP2; Leica Microsystems, GmbH, Wetzlar, Germany). Embryos were washed in M2 between treatments. Fluorescence was detected with bandpass emission filters (Hoechst 33342, 420-480 nm; Cy3, 560-605 nm). Negative control samples in which the primary antibody was omitted were also processed to confirm the specificity of the secondary antibodies used. The primary antibodies used for CRHR1, GR, activated caspase-3 and Fas were goat anti-CRHR1 polyclonal antibodies (1:500, ab59023; Abcam Co., Ltd, Cambridge, MA, USA), rabbit anti-GR polyclonal antibodies (1:1000, ab196944; Abcam Co., Ltd), rabbit anti-activated caspase-3 polyclonal antibodies (1:200, ab2302, Abcam Co., Ltd) and rabbit anti-Fas (1:100, ab82419, Abcam Co., Ltd), respectively. The secondary antibodies for GR, caspase-3 and Fas were Cy3-conjugated AffiniPure goat anti-rabbit IgG (1:200; Jackson ImmunoResearch, West Grove, PA, USA) and those for CRHR1 were Cy3-conjugated rabbit anti-goat IgG (1:500; Jackson ImmunoResearch).
The relative active caspase-3 content of an embryo was quantified by measuring fluorescence intensities of individual blastomeres from 4-cell embryos or early stage morulae. Zona pellucida was removed by treating the paraformaldehyde-fixed embryos with 0.25% protease in M2, and the zona-free embryos were repeatedly pipetted to disperse the blastomeres. Blastomeres were immunostained and observed under a laser confocal microscope. For each experimental series, all images were acquired with identical settings. The relative intensities were measured on the raw images using the Image-Pro Plus software (Media Cybernetics, Inc., Silver Spring, MD, USA) under fixed thresholds across all slides. The average relative fluorescence of the control embryos was set to one, and the averages of treated embryos were expressed relative to this value.
Embryo apoptosis was detected using an Annexin V-FITC staining kit (C1062, Beyotime Institute of Biotechnology, Shanghai, China). Embryos were (i) washed twice in PBS and stained for 10 min in the dark with 195 μl binding buffer containing 5 μl Annexin V-FITC; (ii) incubated for 5 min in M2 containing 10 μg/ml of Hoechst 33342; and (iii) mounted on glass slides and observed under a Leica laser-scanning confocal microscope. Fluorescence was detected with bandpass emission filters (Hoechst 33342, 420-480 nm; FITC, 505-540 nm). Positive staining was revealed as intensely green color spots located on the plasma membrane of blastomeres. A single plane with maximum fluorescence intensity was selected from each embryo and photographed for further analysis. Blastomeres with more than 70% of the plasma membrane showing green fluorescence were considered annexin-positive. Percentages of positive/total blastomeres were calculated to represent the level of embryo apoptosis. For zygote and 4-cell embryos, all the blastomeres were included in the calculation, but for morulae and blastocysts, 8-9 and 12-15 visible blastomeres were calculated, respectively.
Intracellular glutathione assay in embryos or oecs
Samples (each containing 15-20 embryos) or OECs were frozen and thawed three times. The concentrations of total glutathione (GSX) in embryos or OECs were measured using the 5,5′-dithiobis (2-nitrobenzoic acid) (DTNB)-oxidized glutathione (GSSG) reductase-recycling assay. To determine the concentrations of GSSG, the samples were mixed with 2-vinylpyridine and triethanolamine, and after 60 min, the samples were assayed using the DTNB-GSSG reductase-recycling assay. Standards (0.01, 0.02, 0.1, 0.2 and 1.0 mM) of GSX and a sample blank without GSX were also assayed. The amount of GSX in each sample was divided by the number of embryos to calculate the intracellular GSX concentration per embryo. The reduced glutathione (GSH) values were calculated from the difference between GSX and GSSG values for each embryo. The amount of GSX in each sample from OECs was divided by the protein concentration determined with a bicinchoninic acid (BCA) Protein Assay Kit (P0012; Beyotime Institute of Biotechnology) and was expressed as μM/mg protein.
Assay for total oxidant status and total antioxidant status in CM
Assay for total oxidant status (TOS) and total antioxidant status (TAS) was conducted as previously reported (Lian et al., 2013) . Briefly, CM was collected and centrifuged at 1000g for 10 min. For TOS measurement, Reagent 1, which consists of 150 μM xylenol orange, 140 mM NaCl and 1.35 M glycerol in 25 mM H 2 SO 4 solution (pH 1.75), and Reagent 2, which is made of 5 mM ferrous ion and 10 mM o-dianisidine in 25 mM H 2 SO 4 solution, were first prepared. Then, 225 μl Reagent 1, 35 μl sample and 11 μl Reagent two were mixed for reaction. Because the ferrous ion is oxidized to ferric ion in the presence of oxidants in acidic media, the colored complex formed by the ferric ion with xylenol orange can be measured at 560 nm. While the first absorbance was measured before the mixing of Reagents 1 and 2 as sample blank, the last absorbance was recorded when the reaction trace drew plateau line about 3-4 min after the mixing. The measurement was calibrated with H 2 O 2 and the data obtained are expressed in μM H 2 O 2 equivalent (μM H 2 O 2 equiv.).
For TAS measurement, Reagent 1, a 0.4 M acetate buffer (pH 5.8), and Reagent 2, which was made of 10 mM ABTS (2.20-azino-di-[3-ethylbenzthiazoline sulfonate]) in 30 mM acetate buffer (pH 3.6), were first prepared. Then, 200 μl Reagent 1, 5 μl sample and 20 μl Reagent two were mixed for reaction. Because antioxidants in the sample can inhibit oxidation of ABTS, the decrease in colored ABTS+ was measured as a change in absorbance at 660 nm. While the first absorbance was measured before the mixing of Reagents 1 and 2 as sample blank, the last absorbance was recorded 5 min after the mixing. The assay was calibrated with 30 mM Trolox in phosphate buffer (pH 7.4), and the data were expressed in mM Trolox equivalent (mM Trolox equiv.).
To calculate oxidative stress index (OSI), the TAS unit of mM Trolox equivalent was converted into μM Trolox equivalent, and the OSI value was calculated as OSI = (μM H 2 O 2 equiv./μM Trolox equiv.) /100.
Flow cytometry assay
Cell apoptosis in OECs was measured by flow cytometry with Annexin V-FITC/propidium iodide (PI) staining (C1062, Beyotime Institute of Biotechnology). After being washed in PBS, OECs were digested at 37°C with 0.25% trypsin for 5-10 min, and then, DMEM/F12 medium containing 10% fetal bovine serum was added to neutralize the residual trypsin. Cells of each sample were resuspended in 195 μl binding buffer containing 5 μl Annexin V-FITC. After incubating at room temperature in the dark for 10 min, 10 μl PI was added to the cells. The fluorescence of 10 000 cells per sample was analyzed using a Guava easyCyte (Millipore, Boston, MA, USA).
Real-time PCR
Real-time PCR was performed as previously described (Liang et al., 2013) . To isolate RNA, OECs were treated with 1 ml TRIzol reagent. Then, RNA was resuspended in diethyl pyrocarbonate-treated MilliQ water (DEPCdH 2 O) before digestion with RNase-free DNase I (Takara Biotechniques, Dalian, China). The RNA obtained was spectroscopically quantified at 260 nm. To assess RNA purity and integrity, the A260:A280 ratio (1.8-2.0) was determined and electrophoresis in 1% agarose was performed.
A total volume of 20 μl and Superscript III Reverse Transcriptase (Invitrogen Australia Pty., Ltd, Mulgrave, Australia) were used to conduct reverse transcription. (i) 1 μl RNA sample, 1 μl Oligo dT18 (Takara) and 11 μl DEPC-dH 2 O were mixed in a 0.2-ml reaction tube; (ii) the mixture was incubated at 65°C for 10 min in a PCR instrument (Thermo Scientific, Hudson, NH, USA); (iii) the reaction tube was cooled for 2 min on ice before a brief centrifugation (200g, 4°C); (iv) 5X reverse transcription buffer (4 μl), RNase inhibitor (0.5 μl), dNTP (2 μl) and Superscript III Reverse Transcriptase (0.5 μl) were added to the reaction tube; and (v) the mixture was incubated at 55°C for 30 min, at 85°C for 5 min and stored at −20°C until use.
Gene-specific primers for real-time RT-PCR are as follows. For insulinlike growth factor-1 (Igf-1), forward 5′-GGA CCA GAG ACC CTT TGC GGGG-3′, reverse 5′-GGC TGC TTT TGT AGG CTT CAG TGG-3′; for brain derived neurotrophic factor (Bdnf), forward 5′-GCC TCC TCT ACT CTT TCTG-3′, reverse 5′-GGA TTA CAC TTG GTC TCGT-3′; for transforming growth factor-β1(TGF-β1), forward 5′-TGC CCT CTA CAA CCA ACA CA-3′, reverse 5′-GTT GGA CAA CTG CTC CAC CT-3′; for epidermal growth factor (Egf), forward 5′-GGA CTG AGT TGC CCT GAC TC-3′, reverse 5′-CCA CCA TTG AGG CAG TAT CC-3′; for HSD1, forward 5′-ACT CAG ACC TCG CTG TCT CT-3′, reverse 5′-GCT TGC AGA GTA GGG AGC AA-3′; for HSD2, forward 5′-ATC AAT CAC CTT CTG CCC CG-3′, reverse 5′-AAG GGC TGA AGA AGC CCA TC-3′; and for glyceraldehyde-3-phosphate dehydrogenase (Gapdh), forward 5′-AAG GTG GTG AAG CAG GCAT-3′, reverse 5′-GGT CCA GGG TTT CTT ACT CCT-3′.
To perform mRNA quantification, the Mx3005P Real-Time PCR System (Stratagene, Valencia, CA, USA) was used. Amplification was conducted in a 10 μl reaction volume, which included 1 μl of cDNA, 5 μl of 2x SYBR Green Master Mix (Stratagene), 0.15 μl of 500x diluted reference dye, 3.25 μl of RNase-free water, and 0.3 μl each of forward and reverse gene-specific primers (10 μM, the total, final concentration). Cycle amplification conditions included (i) an initial denaturation step at 95°C for 10 min; (ii) 40 cycles at 95°C for 5 s; and (iii) 63°C for 20 s for Igf-1, 60°C for 20 s for Bdnf, 58°C for 20 s for TGF-β1, HSD1 and HSD2. Following amplification, specificity of the reaction was determined by analyzing PCR products via sequencing, dissociation-curve analysis, and gel electrophoresis. Expression of all genes was first normalized to gapdh (internal control), and then, all values were expressed relative to calibrator samples using the 2 −(ΔΔCT) method.
Western blot analysis
Western blotting was conducted as previously reported (Liang et al., 2013) . A radioimmuno-precipitation assay (RIPA) buffer consisting of 150 mM NaCl, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM phenylmethyl sulfonyl fluoride and 50 mM Tris (pH 8) was first prepared. After washing in cooled PBS, OECs were lysed in 100 μl RIPA buffer. Then, the total protein concentration was determined using a BCA Protein Assay Kit (P0012; Beyotime Institute of Biotechnology) and adjusted to 1 μg/μl. After that, 20 μl were placed in a 0.5-ml microfuge tube and frozen at −80°C until use.
For protein extraction, 5 μl of 5x sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer were added to each tube, and the tubes were heated to 100°C for 5 min. SDS-PAGE was run on a 12% polyacrylamide gel to separate total proteins and the proteins obtained were transferred electrophoretically onto polyvinylidene fluoride membranes. Then, the membranes were washed in TBST (150 mM NaCl, 2 mM KCl, 25 mM Tris and 0.05% Tween 20; pH 7.4), blocked with TBST containing 3% BSA at 37°C for 2 h, and incubated at 4°C overnight with primary antibodies. The primary antibodies used included rabbit antiactivated caspase-3 antibodies (1:100, ab2302, Abcam Co., Ltd, Beijing, China), goat anti-CRHR1 polyclonal antibodies (1:400, ab59023, Abcam Co., Ltd), rabbit anti-GR antibodies (1:1000, ab196944, Abcam Co., Ltd), rabbit anti-Fas (1:100, ab82419, Abcam Co., Ltd), and mouse anti-GAPDH monoclonal antibodies (1:1000, CW0100, CWBio Co., Ltd, Beijing, China). After being washed in TBST, the membranes were incubated for 1.5 h at 37°C with alkaline phosphatase-conjugated rabbit antigoat IgG (1:1000, ZB-2311, Zhongshan Golden Bridge Biotechnology Co., Ltd, Beijing, China), goat anti-rabbit IgG (1:500, CW0111, CWBio Co., Ltd) or goat anti-mouse IgG (1:4000, CW0110, CWBio Co., Ltd). Finally, signals were detected using a 5-bromo-4-chloro-3-indolyl phosphate/tetranitroblue tetrazolium chloride alkaline phosphatase color development kit (Beyotime Institute of Biotechnology).
To determine the relative quantities of proteins, the sum density of each protein band image was analyzed using an Image-Pro Plus software (Media Cybernetics, Inc., Silver Spring, MD, USA). The density value of each sample was normalized to that of its internal control GAPDH to get its relative quantity value. The relative quantities of target proteins in control samples were arbitrarily set as one, and the values in treatment samples were expressed relative to this quantity.
ELISA
The ELISA for FasL, EGF, IGF-1, BDNF and TGF-β1 in CM were carried out, respectively, using Mouse Factor Related Apoptosis Ligand (FASL) Elisa kit (BlueGene Co., Shanghai, China), Mouse EGF Quantikine ELISA Kit (R&D Systems, Inc., Minneapolis, MN), Mouse/Rat IGF-I Quantikine ELISA Kit (R&D Systems, Inc., Minneapolis, MN), Mouse BDNF ELISA Kit (Sandwich ELISA, LifeSpan BioSciences, Inc., Seattle, WA, USA) and Mouse TGF beta one ELISA Kit (Abcam Co., Shanghai, China). Assay procedures were performed exactly according to the manufacturer's instructions.
Data analysis
Each treatment was repeated at least three times unless otherwise specified. Percentage data were arc sine-transformed before analysis. Data were analyzed with an independent t-test when each measure contained only two groups but were analyzed using ANOVA when each measure had more than two groups. To locate differences during ANOVA, a Duncan multiple comparison test was performed. The Statistics Package for Social Sciences (SPSS 11.5, SPSS, Inc.) was used. Data are expressed as means ± SEM, and P < 0.05 is defined as significant.
Results
CRH and corticosterone did not have direct effects on embryos in vitro but they impaired embryo development when the cultural system involved OECs
To observe the direct effects of CRH and corticosterone on embryo development, pronuclear mouse embryos were cultured in CZB with or without various concentrations of CRH or corticosterone. Rates of blastocyst formation (78.6-80.7% for CRH, 78.7-81.3% for corticosterone) and cell number per blastocyst (57.6-62.4 for CRH, 60-64.2 for corticosterone) did not differ significantly whether the embryos were exposed to physiological concentrations of CRH (1 × 10 −10 M, Zheng et al., 2016) or corticosterone (1 × 10 −7 M, Burkuš et al., 2013; Gong et al., 2015) , or to supra-physiological concentrations four (1 × 10 −6 M) or two (1 × 10 −5 M) orders of magnitude higher than the physiological concentrations (Fig. 2) . When pronuclear embryos were co-cultured with OECs, however, blastocyst development was impaired significantly with increasing concentrations of CRH or corticosterone. For example, blastocyst rates decreased from 86.9% in co-culture without CRH to 60.9% in co-culture with 2 × 10 −6 M of CRH, and cell number per blastocyst declined from 77 to 55.6. Blastocyst rates decreased from 87.3% in co-culture without corticosterone to 68.5% in co-culture with 1 × 10 −5 M of corticosterone, and cell number per blastocyst declined from 75.2 to 61.2. Furthermore, when pronuclear embryos were cultured in CM from OECs that had been pretreated with CRH or corticosterone (treatment CM), the blastocyst rates and cell number per blastocyst decreased significantly compared to those cultured in control CM (Fig. 2) . Thus, blastocyst rates decreased from 90.8% in control CM to 34.9% in CRH-CM, and cell number per blastocyst declined from 67 to 41.4. Blastocyst rates decreased from 91% in control CM to 33.5% in Cort-CM, and cell number per blastocyst declined from 66 to 43. However, when embryos were cultured in treatment CM in the presence of CRH or corticosterone antagonists, blastocyst rates and cell number per blastocyst increased to the same level as in control CM. Taken together, the results suggest that neither CRH nor corticosterone impair embryo development by a direct action on the embryo but they did so indirectly through affecting OECs, and that CRH and corticosterone were nontoxic to OECs when used at the concentrations tested because embryo development was unaffected in treatment CM in the presence of hormone antagonists.
Culture in treatment CM induced oxidative stress and apoptosis in mouse embryos
To observe whether culture in treatment CM would cause oxidative stress, GSH levels in blastocysts were examined after embryo culture in control or treatment CM. Although the GSX level did not differ between control and treatment CM, while the GSSG level increased, the GSH level decreased significantly, leading to a significant decrease in the GSH/GSSG ratio in treatment CM (Fig. 3) .
Quantification of active caspase-3 in blastomeres indicated that culture in treatment CM significantly increased active caspase-3 expression in both 4-cell embryos and morulae. While none of the zygotes and few of the 4-cell embryos were annexin-positive, morulae and blastocysts showed more annexin-positive cells (Fig. 3) . Percentages of annexin-positive cells were significantly higher when embryos were cultured in treatment CM than in control CM. Taken together, the results suggest that culture in CM conditioned with CRH-or corticosterone-treated OECs induced oxidative stress and apoptosis in mouse embryos.
Expression of CRHR1, GR, active caspase-3 and Fas in mouse embryos at different developmental stages
Expression of GR, active caspase-3 and Fas proteins in preimplantation embryos was examined by immunofluorescence. The results showed that GR, active caspase-3 and Fas proteins were expressed in preimplantation embryos at all the preimplantation stages observed (Fig. 4) . While GR was mainly localized in the cytoplasm of blastomeres, active caspase-3 was localized mainly on the membrane of blastomeres. Fas receptors were localized on the plasma membrane as well as in the cytoplasm. Mouse embryos did not express CRHR1 until the blastocyst stage where it was localized mainly on the plasma membrane. To further confirm that preimplantation mouse embryos did not express CRHR1 until the blastocyst stage, late morulae collected after 78 h of culture were examined for CRHR1 expression, which revealed no CRHR1 expression either (data not shown). The results suggest that CRH did not damage preimplantation mouse embryos directly because they did not express CRHR until the blastocyst stage.
Mouse embryos expressed HSD2 but not HSD1
To answer the question why mouse preimplantation embryos were insensitive to corticosterone while expressing GR, mRNA expression of HSD1 and HSD2 in mouse embryos was assessed by real-time PCR, because it is known that the actions of glucocorticoids are modulated by two isoforms of HSD: whereas HSD1 acts predominantly to generate active cortisol or corticosterone, HSD2 catalyzes the conversion of glucocorticoids to the inactive cortisone. Zygotes were cultured in CZB with or without 1 × 10 −5 M corticosterone, and 4-cell embryos and blastocysts were recovered after 42 h and 96 h of culture, respectively, for PCR assays. The results show that mouse embryos at both 4-cell and blastocyst stages expressed HSD2 but not HSD1. The level of HSD2 mRNA in blastocysts was significantly higher after embryo culture with (1.27 ± 0.07) than without corticosterone (1.0 ± 0.0), although the HSD2 mRNA level in 4-cell embryos did not
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Zygote 4-cell Morula Blastocyst Figure 4 Expression of corticotrophin-releasing hormone receptor 1 (CRHR1), glucocorticoid receptor (GR), active caspase-3, and Fas in mouse in vitro developing embryos at zygote, 4-cell, morula and blastocyst stages. While zygotes were observed immediately after collection from oviducts, 4-cell embryos, morula and blastocysts were observed at 42, 66 and 96 h, respectively, after culture in control CM conditioned with untreated OECs. The micrographs are merged images from laser confocal microscopy with target proteins and DNA colored red and blue, respectively. The bar is 14 μm and applies to all images. differ between culture with (1.02 ± 0.12) and without corticosterone (1.0 ± 0.0) (Fig. 5A) . To further verify that there is no HSD1 expression in mouse embryos, a general PCR amplification of HSD1 and HSD2 mRNAs in 4-cell embryos was conducted using liver or ovaries as positive controls. The results indicated that although expression of HSD1 mRNA was obvious in the liver, no HSD1 expression was observed in the embryos (Fig. 5B) . In contrast, HSD2 mRNA was detected in embryos as well as in the ovaries (Fig. 5C) . The results further confirm that there is no HSD1 mRNA expression in the mouse embryos. Together, the results suggest that mouse embryos are insensitive to corticosterone because they secrete HSD2 that could inactivate corticosterone to cortisone, and that the cortisone produced could not be reactivated, as the embryos do not secrete HSD1.
Culture with CRH or corticosterone induced oxidative stress and apoptosis in OECs
To study whether CRH and corticosterone trigger apoptosis of OECs, OECs monolayer were first cultured for 48 h in CZB without (control) or with 2 × 10 −6 CRH or 1 × 10 −5 corticosterone, and then cultured for 24 h in CZB without hormone supplementation. At the end of the culture, CM and OECs were harvested for analysis of redox status and apoptosis. Whereas the OSI in CM was higher (Fig. 6A) , the GSH/ GSSG ratio in OECs was lower (Fig. 6B) significantly, in OECs treated with either CRH or corticosterone than in non-treated control OECs. Our flow cytometry analysis showed that whereas percentages of healthy cells were lower, percentages of the early apoptotic cells were higher significantly in CRH-or Cort-treated OECs than in control OECs (Fig. 6C) . Furthermore, levels of active caspase-3 expression were significantly higher in CRH-or Cort-treated OECs than in control OECs (Fig. 6D) . Taken together, the results suggest that CRH and corticosterone caused oxidative stress and triggered apoptosis in OECs.
Culture of OECs with CRH or corticosterone impaired expression of growth factors
To determine whether CRH and corticosterone impair OECs' secretion of growth factors, mRNA levels of Bdnf, Igf-1, Egf and Tgf-β1 in OECs was analyzed by real-time PCR and protein levels of these growth factors in CM were measured by ELISA. The results showed that compared to those when OECs were cultured without hormones, levels of both mRNA in OECs (Fig. 7A-C) and protein in CM ( Fig. 7E-G) of BDNF, IGF-1 and TGF-β1 decreased significantly when OECs were cultured with either CRH or corticosterone, suggesting that CRH and corticosterone impaired embryo development by decreasing OECs production of growth factors. However, neither our real-time PCR nor our ELISA showed any Egf mRNA in OECs or EGF protein in CM (data not shown). Furthermore, our general PCR amplification did not show any Egf mRNA in mouse oviducts, although it revealed a significant Egf mRNA expression in the mandibular glands of mice (Fig. 7D) . Effects of culture with CRH or corticosterone on CRHR1, GR and Fas expression in OECs and on the level of FasL in CM To study the mechanisms by which CRH and corticosterone trigger OECs apoptosis, expression of CRHR, GR and Fas in OECs and the level of FasL in CM were observed after culture of OECs with or without CRH or corticosterone. Whereas levels of CRHR1 and Fas expression increased, the level of GR expression decreased significantly following CRH or corticosterone treatment (Fig. 8) . Furthermore, the concentration of FasL in CM was significantly higher after OECs were treated with either CRH or corticosterone than in non-treated control groups. The results suggest that CRH and corticosterone caused OECs apoptosis by acting on their receptors and by activating the Fas system.
Experiments with gld mice
To further confirm that CRH and corticosterone impair embryo development by causing OECs apoptosis via activating the Fas system, experiments were conducted using gld mice harboring FasL mutations. Pronuclear embryos recovered from Kunming mice were cultured in CM conditioned with CRH-or corticosterone-treated OECs from wild-type or gld mice. The results show that blastocyst development was significantly better in CM conditioned with gld OECs compared to that in CM conditioned with OECs from wild-type mice (Fig. 9) . The results further confirmed that CRH and corticosterone impaired embryo development by causing OECs apoptosis via activating the Fas system.
Discussion
The present results showed that blastocyst development was unaffected when mouse zygotes were cultured in CZB medium with various concentrations of CRH or corticosterone but the development was significantly impaired when embryos were co-cultured with OECs in the presence of CRH or corticosterone or when they were cultured in CM conditioned with CRH-or corticosterone-treated OECs. Our further observations indicated that culture in CM conditioned with CRH-or corticosterone-treated OECs induced oxidative stress and apoptosis in embryos. In spite of an arduous search, we could not find any report on the direct effects of CRH or cortisol/corticosterone on preimplantation embryos when the embryos were cultured in the presence of either hormone. The only paper we could find reported that glucocorticoids did not affect embryonic size when bovine embryos collected from superovulated cows on Day 8 after mating were cultured for 5 days in vitro with dexamethasone (al-Hozab and Menino, 1992) . Why did CRH and corticosterone not affect embryos directly? The present results indicated that mouse embryos expressed GR at all the preimplantation stages but they did not express CRHR1 until the blastocyst stage. Mouse 4-cell embryos and blastocysts expressed HSD2 but not HSD1. In target organs, the action of glucocorticoids is primarily determined by the level of GR and active glucocorticoids locally available to GR. Two glucocorticoid metabolizing enzymes, HSD1 and HSD2, are responsible for regulating the levels of active glucocorticoids; while HSD1 mainly activates (reduces) cortisone to cortisol or corticosterone, HSD2 inactivates (oxidizes) cortisol or corticosterone to cortisone (Albiston et al., 1994; Michael et al., 2003) . It is also known that CRH functions by binding to the CRHR in the target cells (Hauger et al., 2003) . Taken together, the present results suggest that mouse preimplantation embryos are insensitive to CRH because they do not express CRHR until the blastocyst stage, and they are not harmed by corticosterone because they express HSD2 exclusively without any HSD1 expression leading to the conversion of active corticosterone to inactive cortisone (Fig. 10) .
Reports on the expression of GR, CRHR, and HSD1 and HSD2 in preimplantation embryos are limited, to our knowledge. Our recent study observed that in vivo produced mouse embryos expressed GR protein at all the preimplantation stages but they did not express CRHR1 protein until the blastocyst stage (Zheng et al., 2016) . Siemieniuch et al. (2010) observed mRNA expression of GR in bovine embryos at all the preimplantation stages. Dinopoulou et al. (2013) observed expression of CRHR1 mRNA in morulae/blastocysts of mice but they conducted their PCR assays with morulae and blastocysts mixed together. Although the current study observed only HSD2 but no HSD1 mRNA expression in mouse 4-cell embryos and blastocysts, Siemieniuch et al. (2010) demonstrated mRNA expression of both HSD1 and HSD2 in bovine embryos at all the preimplantation stages. While Tetsuka et al. (2016) found that bovine cumulusdenuded oocytes (DOs) expressed both HSD2 and HSD1 mRNA, another study in this laboratory showed that mouse DOs exclusively expressed HSD2 without HSD1 mRNA expression (Gong et al., 2017) . Thus, whether the species difference in the HSD1/HSD2 expression pattern observed between mouse and bovine embryos is derived from the different HSD1/HSD2 expression patterns in DOs is worth exploring. Thompson et al. (2004) demonstrated tissue-and developmental-stage specific expression of HSD1 and HSD2 in the postimplantation mouse embryos from embryonic Day 12.5 to postnatal Day 0.5, emphasizing the importance of the two enzymes in regulating glucocorticoid-mediated maturational events in specific tissues during development.
How did CRH and corticosterone induce apoptosis in OECs? The current results showed that culture of OECs with CRH or corticosterone increased their levels of oxidative stress, CRHR1 and Fas expression, and FasL secretion while decreasing their expression of GR and growth factors, leading to apoptosis (Fig. 10) . Blastocyst development in CM conditioned with CRH-or corticosterone-treated OECs was better when the OECs were from gld mice harboring FasL mutations than when the OECs were from wild-type mice. It has been reported that CRH upregulates CRHR1. For example, CRH significantly increased the mRNA level of endogenous CRHR1 in teratocarcinoma (NT2) and breast adenocarcinoma (MCF7) cells (Parham et al., 2004) . Exogenous CRH upregulated CRHR1 mRNA in the paraventricular nucleus of rat hypothalamus (Mansi et al., 1996) . It has also been reported that glucocorticoids decreases GR expression. For example, treatment with glucocorticoids decreased GR protein and/ or mRNA in the rat brain (Chao et al., 1998; Hügin-Flores et al., 2004) and in other somatic cells (Okret et al., 1986; Rosewicz et al., 1988) .
There are also reports that glucocorticoids and CRH can induce cell apoptosis by increasing oxidative stress. Glucorticoids induced death of lymphocytes with a significant generation of reactive oxygen species (ROS) (Zamzami et al., 1995) . The glucocorticoid-induced Leydig cell death is accompanied by activation of the Fas system, cleavage of procaspase-3 and increased ROS generation (Gao et al., 2003) . Dexamethasone treatment of muscle cells induced ROS elevation resulting in apoptosis (Oshima et al., 2004) . CRH significantly increased ROS content, catalase activity and superoxide dismutase activity in endothelial cells (Gougoura et al., 2010) . Furthermore, CRH increased the production of superoxide anion in rabbit peritoneal macrophages (Koshida and Kotake, 1994) and of reactive oxygen intermediates in mouse microglial cells (Yang et al., 2005) . It has also been reported that glucocorticoids and CRH activate the Fas system. Dexamethasone treatment of mice significantly increased FasL expression in testicular germ cells (Khorsandi et al., 2008) . In human, the cortisol level was positively correlated with counts of FasL-positive T cells (Papathanassoglou et al., 2015) . Elevated glucocorticoids weaken their anti-inflammatory effect by decreasing GR expression (Yang et al., 1989; Dinkel et al., 2003) . Furthermore, there are also reports that CRH increases FasL expression (Dermitzaki et al., 2002; Taliouri et al., 2013) . Then, how did the apoptotic OECs induce apoptosis in embryos? The present results indicated that mouse embryos expressed Fas at all the preimplantation stages. Culture of embryos in CM conditioned with CRH/corticosterone-treated OECs induced oxidative stress and apoptosis. Together with our results that culture of OECs with either CRH or corticosterone significantly decreased mRNA and protein levels of BDNF, IGF-1 and TGF-β1 while increasing the production of FasL, it is suggested that the apoptotic OECs triggered embryo apoptosis mainly by producing more FasL but less growth factors. Thus, the FasL interacted with Fas on the embryo leading to an elevation of H 2 O 2 , which, together with a shortage of growth factors, triggered apoptosis of embryos (Fig. 10) . It is known that Fas signaling can induce apoptosis in various cells and tissues (Ju et al., 1995) . Fas expression has also been demonstrated in mouse embryos in vivo (Zheng et al., 2016) . Furthermore, it has been reported that oxidative stress triggered apoptosis in mouse embryos (Qian et al., 2016) .
An interesting observation in this study was that when the culture systems involved neither CRH nor corticosterone, blastocyst rates (78.6 ± 2.4% vs 88.9 ± 2.5%) and cell number/blastocyst (57.6 ± 3.8 cells vs 72 ± 4.6 cells) were significantly (P < 0.05) lower when zygotes were cultured solely in CZB than when co-cultured with OECs or when cultured in CM conditioned with OECs. This result further substantiates our conclusion that OECs-secreted factors are important for embryo development. Our early study observed significant beneficial effects of coculture with OECs on mouse pronuclear embryo development in vitro (Tan et al., 2007) . It is well known that oviducts secrete growth factors, which play an essential role in preimplantation embryo development. For example, IGF-1, IGF-2 and their receptors were expressed in mouse oviducts and uteri (Dalton et al., 1994; Heyner, 1997; Zakaria et al., 2009) . BDNF and its receptors were detected in oviducts and uteri of mice (Kawamura et al., 2007) and ewes (Mirshokraei et al., 2013) . Both IGF-1 (Yoon et al., 2013) and BDNF (Kawamura et al., 2007) have been found to promote embryo development in vitro by their anti-apoptotic effects. Furthermore, TGF-β1 and its receptors were expressed in mouse oviducts and preimplantation embryos, respectively (Dalton et al., 1994; Chow et al., 2001) .
In summary, although studies show that stress impairs embryo development with facilitated secretion of CRH and glucocorticoids, the mechanisms by which these stress-induced hormones affect embryos are unclear. Although our previous in vivo study showed that preimplantation stress impaired embryo development with oviductal apoptosis and activation of the Fas system, whether CRH or glucocorticoids damage embryos directly or indirectly by way of oviductal cells remains to be clarified in vitro. We have studied in vitro the mechanisms by which CRH and corticosterone impair development of the preimplantation embryos. The results showed that CRH and corticosterone do not affect preimplantation embryos directly, but impair their development indirectly by triggering apoptosis of OECs through activation of the Fas system. The insensitivity of preimplantation embryos to CRH and corticosterone is due to, respectively, a lack of CRHR and the expression of HSD2 that inactivates corticosterone. The data are important for our understanding of the mechanisms by which stress affects female reproduction in both human and animals, as early stages of pregnancy are considered more vulnerable to stress than the late stages. Figure 10 Possible pathways by which corticotrophin-releasing hormone (CRH) or corticosterone impairs preimplantation embryo development as revealed by in vitro assays. The present results indicated that CRH and corticosterone did not affect embryo development directly but they did so indirectly by causing apoptosis of oviductal epithelial cells (OECs). Thus, following treatment of OECs with CRH or corticosterone, while GR expression decreased, levels of CRHR1, Fas, FasL and H 2 O 2 went up significantly, leading to apoptosis. The apoptotic OECs produced more FasL but less growth factors. FasL interacted with Fas on the embryo leading to an elevation of H 2 O 2 , which, together with a shortage of growth factors, triggered apoptosis of embryos. Mouse preimplantation embryos were insensitive to CRH because they did not express CRHR until the blastocyst stage, and they were not harmed by corticosterone due to their expression of HSD2 that converted corticosterone to inactive cortisone.
